Related Experiment Videos
On gestagen treatment of advanced prostatic carcinoma
Scandinavian Journal of Urology and Nephrology
|January 1, 1978
Abstract:
Depostat treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study the clinical effect on prostatic cancer was, however, disappointing when compared to the well established effect of orchiectomy. The therapeutic failure of Depostat might be related to the incomplete suppression of plasma testosterone compared to that observed after orchiectomy.